| 영문 | obesity | 한글 | 비만증 |
|---|---|---|---|
| 설명 | 신체에 지방이 과잉으로 축적되어 골격상 및 육체상 요구의 한계 이상으로 체중이 증가된 상태이다. 그러나 체지방의 측정은 쉽지 않기 때문에 수분류나 근육증가의 경우를 빼고, 일반적으로는 체중증가와 동의어로 생각되어 표준체중(이상체중)을 10~20% 넘는 경우를 비만이라 정의한다. 흡수 칼로리가 소비 칼로리를 넘을 때는 그 차를 중성지방으로 해서 지방세포에 축적되어지는 결과 체지방이 증가한다. 쿠싱증후군, 시상하부손상 등에도 비만이 나타난다. 비만, 특히 복부 비만은 여러 질환, 특히 성인병이라고 하는 질환의 발생과 관련이 있는 것으로 알려져 있다. 비만도의 평가에는 체중을 측정하는 방법, 피부주름두께 측정법(캘리퍼를 사용)이 있다. 비만도 지수를 평가하는 임상적인 방법에는 이상체중법(modified Broca's method)으로 가장 쉽게 사용하는 방법이며 [신장(cm)－100]×0.9를 이상체중으로 계산하여 현재체중을 백분율화시킨 방법이다. 비만도 = (실측체중－표준체중)/표준체중×100%로 계산한다. 비만의 원인으로는 유전적 요인, 환경적 요인, 에너지 대사의 이상 등이 있다. 비만의 종류에는 원인에 따라서, 단순 비만과 증후성 비만으로 분류할 수 있다. 단순 비만은 과식과 운동 부족이 그 원인이며, 증후성 비만은 내분비, 시상하부성, 유전 및 대사성 등으로 발생한다. |
||
| 영문 | venereal disease, sexually transmitted diseases | 한글 | 성병 |
|---|---|---|---|
| 설명 | 보편적으로 성교 또는 성기접촉에 의해 걸리는 접촉 전염병으로 매독, 임질, 무른궤양, 샅굴육아종 등을 말한다. 치료는 원인균에 따른 적절한 항생요법이다. |
||
| 영문 | psychosomatic diseases | 한글 | 정신신체질환 |
|---|---|---|---|
| 설명 | 여러 가지 정신적인 원인에 의한 신체 증상을 특징으로 하는 정신질환과 신체 질환의 혼합형을 이르는 말로, 정신 질환의 여러 가지 증상이 신체 증상으로 발현되는 질환이다. 신체 증상은 여러 다양한 장기가 관여하거나 또는 한 장기만 관여한다. |
||
| ICD | I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso... |
|---|---|
| AMD | acid maltase deficiency; acromandibular dysplasia; actinomycin D; adrenomyelodystrophy; age-related ... |
| DDRT | diseases, disorders and related topics |
| ICD-10 | International Statistical Classification of Diseases and Health-related Problems, 10th revision |
| NINCDS/ADRDA | National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Rel... |
| DIO | Diet-induced obesity |
|---|---|
| OHS | Obesity Hypoventilation Syndrome |
| %OB | obesity |
| AID | Auto-immune diseases |
| CVD | Collagen vascular diseases |
| diseases, obesity-related | Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
|---|---|
| obesity-related diseases | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| risks, obesity-related | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness) (12 Dec 1998) |
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
| central obesity | The deposition of obesity around the trunk sparing the limbs. (27 Sep 1997) |
| morbid obesity | Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition. Simple obesity, obesity resulting when caloric intake exceeds energy expenditure. (05 Mar 2000) |
| hypothalamic obesity with hypogonadism | A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms. Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism. Origin: L. Fr. G. Dys-, bad, + trophe, nourishment (05 Mar 2000) |
| obesity | <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Origin: L. Obesus = fat (18 Nov 1997) |
| obesity index | Body weight divided by body volume. (05 Mar 2000) |
| obesity, morbid | The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. (12 Dec 1998) |
| adhesion-related kinase | <chemical> New member of the immunoglobulin superfamily with 2 immunoglobulin-like domains Synonym: ark protein, ark receptor tyrosine kinase (26 Jun 1999) |
| age-related macular degeneration | A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision. (05 Mar 2000) |
| aids-related complex | A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids. (12 Dec 1998) |
| aids-related opportunistic infections | Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus. (12 Dec 1998) |
| AIDS-related virus | An obsolete term for human immunodeficiency virus. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|